Hip Arthropathy Clinical Trial
Official title:
Quality of Life, Functional Outcomes and Costs in Patients Undergoing Primary Total Hip Arthroplasty
This prospective observational study aims to collect and analyse data on functional outcomes, quality of life indicators, and costs in patients undergoing primary total hip arthroplasty (hip replacement) surgery.
Primary total hip replacement surgery (also called primary total hip arthroplasty) has been shown to be a safe and reliable procedure for the treatment of degenerative joint disease, which can improve the functional and overall quality of life among patients. This prospective observational study aims to explore how undergoing these surgeries affects patients' functional outcomes and quality of life indicators. Another purpose of this research is to evaluate the costs that generate from this surgical intervention and relate them to the gains in functional outcomes and quality of life measures by conducting cost-utility analysis (CUA). Participants of this study will be men and non-pregnant women over the age of 18 who are undergoing primary total hip replacement surgery at the Traumatology, Orthopedics and Joint Pathology Clinic of the I.M. Sechenov First Moscow State Medical University (Sechenov University). At this facility, around 300 total hip replacement surgeries are performed annually. Functional outcomes and quality of life indicators will be measured with validated questionnaires. The Western Ontario and McMaster Universities Arthritis Index (WOMAC) will be used to measure functional outcomes in patients undergoing hip arthroplasty, the 5-level version of the EuroQol-5 Dimension questionnaire (EQ-5D-5L) will be used to measure their health-related quality of life. Questionnaires will be administered to patients before they undergo the procedure and on several follow-up dates (6 weeks, 3 months, 6 months, 1 year after the procedure). Before the surgery the questionnaires will be provided to patients in print form. At other points in time the questionnaires will be administered over the phone or via online forms (way of questionnaire administration depends on the choices of patients). In addition to tracking changes in patients' functional outcomes and quality of life indicators, patients will be surveyed about all direct and indirect costs generated from seeking treatment for their condition, undergoing the replacement surgery, and the rehabilitation process. A small sample of patients will be interviewed about the costs borne by them to produce a questionnaire which will be used to survey the other patients. Cost information will be collected at the same points in time and in the same formats as stated above (printed questionnaires, telephone surveys, online forms). Financial data for calculating costs borne by the clinic will be obtained from the cost accounting system of the facility after each patient's discharge. Afterwards, the collected cost information will be applied to the CUA. Using quality-adjusted life-years (QALYs) and monetary estimates of costs, Average Cost-Utility Ratios (ACURs) will be calculated for primary total hip replacement surgeries. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05556759 -
Anterior Iliopsoas Muscle Space Block Versus Supra-iliac Anterior Quadratus Lumborum Block in Total Hip Arthroplasty
|
N/A | |
| Withdrawn |
NCT05030688 -
Fascia Iliaca Compartment Block and PENG Block for Hip Arthroplasty
|
N/A | |
| Not yet recruiting |
NCT05015517 -
ESP Block vs FIB in Patients Undergoing Hip Arthroplasty
|
N/A | |
| Completed |
NCT05134207 -
The Effect of Oral Carbohydrate Solution on Anxiety and Comfort in Patients Undergoing Hip Arthroplasty
|
N/A | |
| Recruiting |
NCT04438265 -
Quadratus Lumborum Type 2 as Chronic Hip Pain Treatment
|
||
| Recruiting |
NCT04229368 -
Effect of Vitamin D Status and Repletion on Postoperative Total Joint Arthroplasty Complications
|
N/A | |
| Active, not recruiting |
NCT05142462 -
Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup
|
||
| Active, not recruiting |
NCT06083428 -
Erector Spinae vs. PENG Block for Total Hip Arthroplasty
|
Phase 4 | |
| Completed |
NCT05396924 -
Rectal Temperature Measurement in Detecting Hypothermia During Hip Arthroscopy
|
N/A | |
| Active, not recruiting |
NCT05524363 -
Assessment of Safety and Performances of HYPE SCS Stem Associated to NOVAE Sunfit TH Acetabular Cup in Hip Arthroplasty
|
||
| Recruiting |
NCT06147401 -
Comparison of PENG Associated With LFCN Block Versus FICB for Multimodal Analgesic Management in THA
|
N/A | |
| Completed |
NCT03977454 -
Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty
|
Phase 2 | |
| Recruiting |
NCT05397145 -
Iliopsoas Plane Block vs PENG Block for Hip Arthroplasty
|
N/A | |
| Completed |
NCT03981354 -
Nutritional Status and Its Modifications After Hip Replacement
|
||
| Active, not recruiting |
NCT04995822 -
Post Market Clinical Follow-up of EUROSTEM Femoral Stem
|
||
| Completed |
NCT04883788 -
The Impact of COVID-19 Pandemic on Hip and Knee Replacement
|
||
| Not yet recruiting |
NCT06317870 -
Pericapsular Nerve Block Versus Intrathecal Morphine for Analgesia After Primary Hip Arthroplasty
|
N/A | |
| Completed |
NCT03541798 -
Comparison of Three Different Sitting Positions for Performing Combined Spinal-Epidural Anesthesia
|
N/A | |
| Completed |
NCT04306133 -
PENG Block Combined to Wound Infiltration for Hip Replacement
|
N/A | |
| Completed |
NCT04123873 -
Effect of Combinations of Paracetamol, Ibuprofen, and Dexamethasone on Patient-Controlled Morphine Consumption in the First 24 Hours After Total Hip Arthroplasty
|
Phase 4 |